Showing results (421-430 of 528) with videos related to

Sort By:
Pageof 53
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trialAntonio Santo, Sara Pilotto, Domenico Galetta, et al.
Oncogene|June 17, 2018
hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axisFrancesca Di Modugno, Sheila Spada, Belinda Palermo, et al.
EMBO Reports|September 10, 2020
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperationRoberta Melchionna, Sheila Spada, Francesca Di Modugno, et al.
Clinical Lung Cancer|February 23, 2021
Recent Advances in the Management of Typical and Atypical Lung CarcinoidsNatalie Prinzi, Roberta Elisa Rossi, Claudia Proto, et al.
Scientific Reports|January 23, 2023
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Therapeutic Advances in Medical Oncology|March 20, 2023
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapyGiovanna Garufi, Luisa Carbognin, Isabella Sperduti, et al.
The Oncologist|June 8, 2021
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority StudyLuigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
BMC Cancer|August 23, 2022
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 studyLuigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
The Journal of Pathology|November 23, 2016
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2DMichele Simbolo, Andrea Mafficini, Katarzyna O Sikora, et al.
Therapeutic Advances in Medical Oncology|November 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevanceSara Pilotto, Lorenzo Belluomini, Federico Monaca, et al.
Pageof 53